Medicine overview
Indications of Clascon
Clascon is a topical androgen receptor inhibitor indicated for the treatment of acne vulgaris.
- FDA-approved use: Topical treatment of acne vulgaris in patients 12 years of age and older.
- Notable feature: Unlike systemic antiandrogen therapies (e.g., spironolactone) that are generally limited to female patients due to hormonal side effects, Clascon acts locally within the skin and blocks androgen receptors in the sebaceous gland and hair follicle without significant systemic hormonal activity when used as directed, making it suitable for use in both males and females.
- Evidence base: Efficacy was established in randomized, double-blind, vehicle-controlled clinical trials in patients with facial acne vulgaris.
- Not indicated for acne outside the labeled age group, and not established for other androgen-mediated skin conditions.
Composition
Each gram of Clascoterone cream typically contains Clascoterone 10 mg (1% w/w) in a topical cream base. Strength and excipients may vary by manufacturer/brand; refer to the specific product packaging for exact composition.
Description
Clascon is a synthetic topical androgen receptor inhibitor used in the management of acne vulgaris. It represents a distinct mechanistic class of acne therapy, acting directly at the site of application to competitively block androgen receptors in the skin, thereby reducing the hormonal drivers of sebum production and inflammation that contribute to acne. It is formulated as a topical cream for external use only.
Therapeutic Class
Clascon belongs to the therapeutic class of topical anti-acne preparations, specifically classified as a topical androgen receptor inhibitor (topical antiandrogen).
Pharmacology
Mechanism of Action
Clascoterone is structurally similar to spironolactone and works by binding to and blocking androgen receptors located in the sebaceous glands and outer root sheath of hair follicles in the skin. By inhibiting androgen-receptor-mediated signaling locally, Clascoterone reduces sebum production and downstream inflammatory pathways that contribute to the development of acne lesions.
Pharmacokinetics
Clascoterone is designed for local activity with limited systemic absorption when applied topically as directed. Systemic exposure that does occur is rapidly metabolized (primarily via ester hydrolysis) into inactive metabolites, which is thought to minimize systemic antiandrogenic effects under normal use conditions. Despite this favorable profile, systemic absorption is not zero, and caution is still warranted (see Precautions and Use in Special Populations).
Dosage & Administration of Clascon
| Indication | Population | Recommended Regimen |
|---|---|---|
| Acne vulgaris | Adults and adolescents 12 years and older | Apply a thin layer of Clascon cream (approximately 1 gram) to the affected area(s) twice daily, once in the morning and once in the evening. |
| Acne vulgaris | Children under 12 years | Safety and efficacy not established; not recommended. |
For external/topical use on the skin only. Wash and dry the affected area gently before application. Avoid contact with eyes, lips, mouth, and other mucous membranes; if accidental contact occurs, rinse thoroughly with water. Wash hands after application unless the hands are a treated area. If irritation occurs, application frequency may be reduced; consult a physician if irritation persists or worsens.
Administration of Clascon
Clascon cream is for topical (external) use only. Apply a thin, even layer to clean, dry, affected skin, avoiding the eyes, lips, and mucous membranes. Do not apply to broken or irritated skin unless directed by a physician. Not for oral, ophthalmic, or vaginal use.
Interaction of Clascon
No clinically significant drug-drug interaction studies have been formally established for Clascon due to its predominantly local mechanism of action and limited systemic absorption when used as directed.
- Other topical acne products: Concurrent use of other topical acne medications (e.g., retinoids, benzoyl peroxide) may increase the risk of local skin irritation; if combination therapy is used, it should be supervised by a physician and applied with caution (e.g., at different times of day).
- Systemic antiandrogens/hormonal therapy: Theoretical additive antiandrogenic effects are possible with concurrent systemic antiandrogen use, although clinical significance with topical Clascon is expected to be low; inform your physician of all medicines used.
Always inform your physician or pharmacist about all medications, supplements, and topical products in use before starting Clascon.
Contraindications
Clascoterone is contraindicated in patients with known hypersensitivity to Clascoterone or to any component of the formulation.
Side Effects of Clascon
The most commonly reported side effects of Clascon in clinical trials (occurring in approximately 7-12% of patients) include:
- Redness of the skin (erythema)
- Itching (pruritus)
- Scaling or dryness of the skin
Less common effects (reported in more than 3% of patients, at rates similar to the vehicle/placebo cream) include localized swelling (edema), stinging, and burning sensation at the application site. These reactions are usually mild to moderate and may improve with continued use or reduced application frequency. Patients should notify their physician if side effects are severe, persistent, or worsening.
Pregnancy & Lactation
Pregnancy: There are no adequate and well-controlled studies of Clascon use in pregnant women. In animal reproduction studies, malformations were observed at systemic exposures substantially higher (approximately 8 to 39 times) than those expected with recommended topical human use. Clascon should be used during pregnancy only if clearly needed and if the potential benefit justifies the potential risk to the fetus; consult a physician before use if pregnant or planning pregnancy.
Lactation: There is no data on the presence of Clascon in human breast milk, its effects on the breastfed infant, or its effects on milk production. Because systemic absorption is generally limited but not absent, a nursing mother should consult her physician to weigh the benefits of treatment against the potential, though likely low, risk to the infant, and avoid application to the chest/breast area if breastfeeding.
Precautions & Warnings
General Precautions
- For external use only. Clascon is not intended for oral, ophthalmic, or intravaginal use.
- Avoid contact with the eyes, lips, mouth, and mucous membranes; if accidental exposure occurs, rinse thoroughly with water.
- Local skin reactions such as irritation, redness, itching, and peeling may occur, particularly during the initial weeks of treatment. If irritation is significant, reduce the frequency of application or temporarily discontinue use and consult a physician.
HPA Axis Suppression
Hypothalamic-pituitary-adrenal (HPA) axis suppression has been reported with use of Clascon, particularly in adolescent patients, and generally resolved within about 4 weeks after stopping treatment. Physicians may consider evaluation for HPA axis suppression in patients showing signs of adrenal insufficiency.
Hyperkalemia
Elevated potassium levels have been observed in some patients using Clascon in clinical trials. Caution is advised in patients with conditions or concurrent medications that predispose to hyperkalemia.
Limited Long-Term Safety Data
Clascon is a relatively newer topical acne therapy, and long-term safety data beyond clinical trial durations remain limited. Use should be guided by current prescribing information and physician judgment, with attention to updated safety evidence as it becomes available.
Use in Pregnancy/Lactation
Not recommended during pregnancy or breastfeeding without medical guidance; see Pregnancy and Lactation section.
Overdose Effects of Clascon
Clascon is intended for topical use, and clinically significant systemic toxicity from ordinary topical use is unlikely due to limited systemic absorption. However, in the event of accidental ingestion, application of an excessive amount, or if signs of an adverse reaction (such as severe irritation, allergic reaction, or symptoms suggestive of adrenal or hormonal disturbance) occur, seek immediate medical attention or contact a poison control center. Do not attempt to manage a suspected overdose or ingestion at home without professional medical guidance.
Storage Conditions
Store at room temperature (below 30°C), away from light and moisture. Keep the tube tightly closed when not in use. Keep out of reach of children.
Use In Special Populations
Pediatric Use
Safety and efficacy of Clascon have been established in patients 12 to 18 years of age for the treatment of acne vulgaris. Safety and efficacy in children under 12 years of age have not been established. Adolescent patients may be more susceptible to systemic absorption-related effects, including HPA axis suppression; monitor accordingly.
Geriatric Use
Clinical studies of Clascon for acne vulgaris did not include substantial numbers of elderly patients, as acne vulgaris is predominantly a condition of adolescents and younger adults. No specific dose adjustment is established for elderly patients using Clascon for its approved indication.
Renal/Hepatic Impairment
Specific dose-adjustment studies in renal or hepatic impairment have not been established for topical Clascon; given its intended limited systemic absorption, no dose adjustment is generally required, but caution and physician guidance are advised in patients with significant hepatic or renal disease.
Duration Of Treatment
Clinical improvement in acne with Clascon may take several weeks of consistent, twice-daily use to become apparent, generally assessed over a treatment course of 12 weeks in clinical trials. Treatment duration should be individualized by the prescribing physician based on clinical response; do not discontinue prematurely without medical advice, and do not use for longer than recommended without follow-up evaluation.
Drug Classes
Topical androgen receptor inhibitor; topical anti-acne agent.
Mode Of Action
Clascoterone competitively binds to androgen receptors in the sebaceous glands and hair follicles of the skin, blocking the effects of androgens (such as testosterone and dihydrotestosterone) at the local tissue level. This reduces androgen-driven sebum production and inflammatory signaling that contribute to acne lesion formation, without requiring systemic antiandrogenic activity to achieve its therapeutic effect.
Pediatric Uses
Clascon is approved for use in patients 12 years of age and older for the topical treatment of acne vulgaris. It has not been studied and is not recommended for children under 12 years of age. Adolescent patients should be monitored for signs of HPA axis suppression, as this population showed somewhat higher susceptibility in clinical trials; symptoms generally resolved within about 4 weeks of stopping treatment.
Frequently Asked Questions
Q: What is Clascon 1% w/w Cream used for?
A: Clascon 1% w/w Cream is a topical cream used to treat acne vulgaris in patients 12 years of age and older. It works by blocking androgen receptors in the skin, which helps reduce the excess oil production and inflammation that lead to acne.
Q: Can both men and women use Clascon 1% w/w Cream?
A: Yes. Unlike some oral antiandrogen medications for acne that are typically used only in female patients due to hormonal side effects, Clascon 1% w/w Cream acts locally on the skin with limited systemic hormonal activity, so it can be used by both male and female patients as prescribed.
Q: How should I apply Clascon 1% w/w Cream cream?
A: Apply a thin layer of Clascon 1% w/w Cream cream to clean, dry, affected skin twice daily, in the morning and evening. Avoid contact with the eyes, lips, mouth, and mucous membranes, and wash your hands after application. Use it exactly as directed by your physician.
Q: What side effects can Clascon 1% w/w Cream cause?
A: The most common side effects of Clascon 1% w/w Cream are redness, itching, and dryness or scaling of the skin at the application site. Less commonly, swelling, stinging, or burning may occur. These effects are usually mild and may lessen with continued use; tell your doctor if they are severe or persistent.
Q: Is Clascon 1% w/w Cream safe during pregnancy or breastfeeding?
A: Safety data on Clascon 1% w/w Cream during pregnancy and breastfeeding are limited. Animal studies showed harm at high exposures, and there is no adequate human data. Clascon 1% w/w Cream should be used during pregnancy or lactation only if clearly needed and if your physician determines the potential benefit outweighs the potential risk; always consult your doctor first.
Q: How long does it take for Clascon 1% w/w Cream to work?
A: Improvement in acne with Clascon 1% w/w Cream typically requires several weeks of consistent, twice-daily use, with clinical studies generally evaluating results over about 12 weeks. Do not stop treatment early or use it longer than prescribed without checking with your physician.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.
